Serum pepsinogen C: A useful marker of Helicobacter pylori eradication?

Journal of Clinical Laboratory Analysis

Volumn 10, Issue 1, 1996, Pages 1-5

  Plebani, Mario ^a,d   Basso, Daniela ^a   Scrigner, Marina ^a   Toma, Andrea ^a   Di Mario, Francesco ^a   Dal Bò, Nadia ^a   Samloff, I Michael ^b,c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d c/o Laboratorio Centrale ^*  (Italy)

Author keywords

gastrin; H. pylori eradication; IgG antibodies anti H; omeprazole; pepsinogen C; peptic ulcer; pylori

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; GASTRIN; IMMUNOGLOBULIN G ANTIBODY; METRONIDAZOLE; OMEPRAZOLE; PEPSINOGEN; PEPSINOGEN II;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC GASTRITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DUODENITIS; DUODENUM ULCER; ENZYME BLOOD LEVEL; FEMALE; GASTRIN BLOOD LEVEL; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; STOMACH BIOPSY; STOMACH ULCER;

ADULT; AGED; ANTI-ULCER AGENTS; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; FEMALE; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OMEPRAZOLE; PEPSINOGENS; REGRESSION ANALYSIS;

EID: 0030061162     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1996)10:1<1::AID-JCLA1>3.0.CO;2-H     Document Type: Article

References (32)

1. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ: Campylobacter pyloridis-associated chronic antral gastritis. Gastroenterology 94:33-40, 1988.
2. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626-633, 1990.
3. Peterson WL: Helicobacter pylon and peptic ulcer disease. N Engl J Med 324:1043-1048, 1991.
4. Mégraud F, Lamouliatte H: Helicobacter pylori and duodenal ulcer: Evidence suggesting causation. Dig Dis Sci 37:769-772, 1992.
5. Saita H, Murakami M, Yoo JK, Teramura S, Dekigai H, Takahashi Y, Kita T: Link between Helicobacter pylori-associated gastritis and duodenal ulcer. Dig Dis Sci 38:117-122, 1993.
6. Forbes, GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ: Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up. Lancet 343:258-260, 1994.
7. Fiocca R, Luinetti O, Villani L, ChiaravalliAM, Comaggia M, Stella G: High incidence of Helicobacter pylon colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 5:S2-S8, 1993.
8. Hansson LE, Engstrand L, Nyre'n O, Evans DJ, Lindgren A, Bergstrom R: Helicobacter pylori infection: Indipendent risk indicator of gastric adenocarcinoma. Gastroenterology 105:1098-1103, 1993.
9. Schnell GA, Schubert TT: Usefulness of culture, histology, and urease testing in the detection of Campylobacter pylori. Am J Gastroenterol 84:133-137, 1989.
10. De Mascarel A, Merlio JP: Histologic demonstration of Campylobacter pylori. Gastroenterol Clin Biol 13:26b-30b, 1989.
11. Barthel JS, Everett ED: Diagnosis Campylobacter pylori infection: The "gold standard" and the alternatives. Rew Infect Dis 12:s107-s114, 1990.
12. 14C-urea breath test in C. pylori gastritis. Gut 30:798-803, 1989.
13. Newell DG, Stacey AR: The serology of Campylobacter pylori infections. In Campylobacter pylori and Gastroduodenal Disease. Rathbone BJ, Heatley RV, eds. Blackwell Scientific Publications, London, 1989, p 190-196.
14. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 44:326-328, 1991.
15. Kosunen TU, Seppala K, Sarna S, Sipponen P: Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 339:893-895, 1992.
16. Glupczynski Y, Burette A, Glossens H, De Prez C, Butzler JP: Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbial Infect Dis 11:583-588, 1992.
17. Plebani M, Basso D, Venturini R, De Paoli M, Mantovani G, Di Mario F, Burlina A: Usefulness of two different assays for serodiagnosis of Helicobacter pylori infection. Eur J Lab Med 1:9-12, 1993.
18. Plebani M, Di Mario F, Stanghellini V, Delle Fave G: Serological tests to monitor treatment of Helicobacter pylori. Lancet 340:51-52, 1992.
19. Hunter FM, Correa P, Fontham E, Ruiz B, Sobhan M, Samloff IM: Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 38:2081-1086, 1993.
20. Logan R: Urea breath tests for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 5:S46-S49, 1993.
21. Plebani M, Di Mario F, Vianello F, Perobelli L, Ceriotti G, Naccarato R: Pepsinogen group I radioimmunoassay and total pepsinogen colorimetric determination: A comparative study in normal subjects and in peptic ulcer patients. Clin Biochem 16:20-22, 1983.
22. Plebani M, Masiero M, Di Mario F, Boniolo A, Burlina A: Radioimmunoassay for Pepsinogen C. Clin Chem 36:1690, 1990.
23. Di Mario F, Plebani M, Gottardello L, Battaglia G, Vianello F, Farinati F, Del Favero G: Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal ulcer disease. Clin Biochem 25:121-124, 1992.
24. Hanley JA, McNeil BJ: The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 143:29-36, 1982.
25. Hanley JA, McNeil BJ: A method of comparing the area under Receiver Operating Characteristic Curves derived from the same cases. Radiology 148:839-943, 1983.
26. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH: Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. Gastroenterology 100:1571-1575, 1991.
27. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930-932, 1992.
28. Graham DY, Lew GM, Lechago J: Antral G-cell and D-cell numbers in Helicobacter pylori infection: Effect of H. pylori eradication. Gastroenterology 104:1655-1660, 1993.
29. Kosunen TU, Seppala K, Sarna S, Sipponen P: Diagnostic value of decreasing Ig G, Ig A and Ig M antibody titres after eradication of Helicobacter pylori. Lancet 339:893-895, 1992.
30. Misiewicz JJ: The Sidney System: A new classification of gastritis. Introduction. J Gastroenterol Hepatol 6:207-208, 1991.
31. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 83:204-209, 1982.
32. Plebani M: Pepsinogens in health and disease. Crit Rev Clin Lab Sci 30:273-328, 1993.